NSC |
Compound |
Enrichment |
Correlation |
NSC 718781 |
Erlotinib hydrochloride |
0.0348993771550531 |
0.11094278 |
NSC 719667 |
7-methoxy-8-[3-(1,4-oxazinan-4-yl)propoxy-(11aS)-2,3,5,11a -tetrahydro-1H-pyrrolo[2,1-c][1,4]benzodiazepine-5-one |
0.0348993771550531 |
0.03723653 |
NSC 720134 |
Null |
0.0348993771550531 |
0.068144607 |
NSC 729166 |
N,N'-didecyl 4,4'-(1,4-piperazinediyl)bisbenzenecarboximidamide |
0.0348993771550531 |
-0.046729461 |
NSC 731701 |
1[(4-n-butyloxyCarbonyl)piperazine-1-yl]diazene-1-ium-1,2-di olate |
0.0348993771550531 |
0.17021171 |
NSC 731704 |
1-[4-Ethoxycarbonyl)homopiperazine-1-yl]diazen-1-ium-1,2-dio late. |
0.0348993771550531 |
0.18981133 |
NSC 732936 |
5,6-Dihydro-6-(3-dimethylamino-1-propyl)-2,3-methylenedioxy- 5,11-dioxo-11H-indeno[1,2-c]isoquinoline |
0.0348993771550531 |
0.28005099 |
NSC 732962 |
5-amino-4-(1,3-benzothiazol-2-yl)-1-(2-chloro-5-trifluoromet hylphenyl)-2,3-dihydro-1H-3-pyrrolone |
0.0348993771550531 |
0.027909265 |
NSC 740357 |
Null |
0.0348993771550531 |
0.072816151 |
NSC 741425 |
3,7-di(trifluoromethyl)-2-naftoylquioxaline 1,4-dioxide |
0.0348993771550531 |
0.1544221 |